Vaccination strategy – Page 5 – Communicable Diseases Research

Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant

동종 골수 이식 후 2년 미만의 환자에서 1차 COVID-19 예방 접종에 대한 체액 및 세포 반응 손상

Article

Published on 2022-08-012022-09-11
Journal: British Journal of Haematology [Category] MERS, 변종, 진단,

Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs

신흥 SARS-CoV-2 VOC의 Ad5 벡터 스파이크 단백질에 의해 유도된 항체 반응의 비교 특성화

Comparative Study

Published on 2022-07-292022-09-11
Journal: Signal Transduction and Targeted Therapy [Category] COVID19(2023년), MERS, SARS, 변종, 진단,

[키워드] administration Alpha analyzed antibody Antibody Response Antibody responses B.1.351 B.1.429 B.1.617.2 Beta booster Characteristics Comparative cross-neutralizing antibody cross-reactivity Delta Effects elicit elicited Epsilon Gamma Heterologous immune response immune responses Lineage mice Neutralizing Neutralizing antibodies neutralizing antibody Neutralizing antibody response neutralizing antibody responses omicron other variant other variants pandemic produced provided regimens responses against SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Single-dose spike Spike protein Spike proteins Spread stimulate the SARS-CoV-2 the vaccine unique vaccination Vaccination strategy Vaccine Vaccine development variants VoC VOCs
[DOI] 10.1038/s41392-022-01065-0 PMC 바로가기 [Article Type] Comparative Study

Reduced binding activity of vaccine serum to omicron receptor-binding domain

오미크론 수용체 결합 도메인에 대한 백신 혈청의 감소된 결합 활성

Article

Published on 2022-07-282022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus-2 anti-SARS-CoV-2 anti-SARS-CoV-2 antibody antibody assays be positive binding binding activity blood sample China Chinese collected contribute coronavirus disease Coronavirus disease 2019 COVID-19 dimeric domain dropped E. coli Efficacy ELISA expressed homogeneous humoral immunized investigated lateral flow LFD monomeric omicron Omicron variant participant positive prototype raise RBD RBDs reactivity Receptor-binding domain regimen SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV-2 variant sera serum Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 Spike protein Spread subject the SARS-CoV-2 the spike protein Transmission vaccination Vaccination strategy Vaccine variant
[DOI] 10.3389/fimmu.2022.960195 PMC 바로가기 [Article Type] Article

Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients

COVID-19 면역적격 회복기 환자에서 항뉴클레오캡시드 IgG 반응의 동역학

Article

Published on 2022-07-202022-09-11
Journal: Scientific Reports [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법,

[키워드] absence anti-Nucleocapsid IgG anti-SARS-CoV-2 anti-SARS-CoV-2 humoral antibody Antibody Response Antibody testing BMI comprehension convalescent patient Convalescent patients country COVID-19 COVID-19 convalescent patient COVID-19 disease decrease detectable develop disease severity humoral humoral immune response IgG IgG antibodies IgG antibody immunodeficiency inclusion criteria Kinetics knowledge longitudinal study majority Nasopharyngeal swab nasopharyngeal swab sample Nasopharyngeal swab samples nucleocapsid Patient positive Protein Re-infection robust RT- PCR SARS-CoV-2 SARS-CoV-2 nucleocapsid serum Sex Treatment Vaccination strategies Vaccination strategy virus infection
[DOI] 10.1038/s41598-022-16402-0 PMC 바로가기 [Article Type] Article

Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections

1차 SARS-CoV-2 Omicron BA.1 및 BA.2 감염 후 다른 중화 프로필

Article

Published on 2022-07-192022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,

[키워드] activity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody Antibody Response Antibody responses B.1.1.529 B.1.617.2 breakthrough infections contribute controls coronavirus cross-neutralization cross-neutralizing Delta detectable ENhance Humoral immunity Immune escape individual individuals infected individuals Infection lineages Live virus mRNA mRNA vaccination multiple exposures mutated naïve neutralization neutralization test neutralization tests Neutralizing antibodies neutralizing antibody omicron Omicron sub-lineages Omicron variants other variants pre-immune Primary infection profile reduced respiratory SARS-CoV-2 SARS-CoV-2 neutralization SARS-CoV-2 variant SARS-CoV-2 variant of concern SARS-CoV-2 variants serum Serum Neutralization serum sample serum samples severe acute respiratory syndrome Coronavirus specific neutralizing antibodies Spike protein Strains tested These data vaccinated individual vaccinated individuals Vaccination strategies Vaccination strategy Vaccinations variant variants wildtype
[DOI] 10.3389/fimmu.2022.946318 PMC 바로가기 [Article Type] Article

Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy

Reviews

Published on 2022-07-152022-10-05
Journal: Bone marrow transplantation [Category] 치료제,

SARS-CoV-2 testing strategies for outbreak mitigation in vaccinated populations

백신 접종 집단의 발병 완화를 위한 SARS-CoV-2 테스트 전략

Article

Published on 2022-07-132022-09-11
Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종,

Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study

COVID-19 등재 백신 효과의 도시 모니터링, 평가 및 적용: 건강 코드 블록체인 연구

Article

Published on 2022-07-132022-09-11
Journal: BMJ Open [Category] 변종,

[키워드] aggravate Algorithm analysed Analysis Asymptomatic average basic reproduction number calculate city Complete conditions Contact cooperation country COVID-19 decrease deviation Effectiveness eight ENhance epidemiological Epidemiological investigation Epidemiology evaluate greater Health Health policy herd immunity Immunity increase Incubation period index infection rate information measure MONITOR mutant virus not decreased outcome Patient Primary outcome Primary outcomes promote promoted proportion protective effect reduced regions respond second significantly Simulation statistical symptomatic the vaccine this system transmitted urban urban population vaccination vaccination rate Vaccination strategy Vaccine Vaccines variant Variation virus weight
[DOI] 10.1136/bmjopen-2021-057281 PMC 바로가기 [Article Type] Article

Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review

SARS-Cov-2 오미크론 변이체에 대한 COVID-19 백신의 체액 및 세포 면역 반응: 전신 검토

Review

Published on 2022-07-112022-09-11
Journal: International Journal of Biological Sciences [Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed B.1.1.529 booster booster dose cellular Cellular immune response cellular immune responses center contagious coronavirus 2 country COVID-19 vaccine Critical current dominant variant dose Effectiveness elicit elicited Future Genome Health Organization Heterologous homogenous homologous or heterologous humoral Humoral and cellular immune responses humoral immune response humoral immune response, cellular immune response immune Immune escape immune responses induce molecular basis multiple mutation multiple mutations mutated Mutation Neutralizing antibody response neutralizing antibody responses omicron Omicron variant PROTECT Protective public health question regimen regimens reported respiratory response robust S-protein SARS-CoV-2 SARS-CoV-2 strains SARS-CoV-2 virus Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus Systemic review systemically T cell T cell response the SARS-CoV-2 virus vaccination Vaccination strategy Vaccine variant VoC WHO World Health Organization
[DOI] 10.7150/ijbs.73583 PMC 바로가기 [Article Type] Review

Short and mid-term SARS-CoV-2 antibody response after inactivated COVID-19 vaccine in hemodialysis and kidney transplant patients

혈액 투석 및 신장 이식 환자에서 비활성화된 COVID-19 백신 후 단기 및 중기 SARS-CoV-2 항체 반응

Observational Study

Published on 2022-07-012022-09-12
Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 임상, 진단,

[키워드] acute respiratory syndrome Administered age Anti-spike antibody Antibody Response Antibody titer cohorts comparable Control CoronaVac coronavirus coronavirus disease COVID-19 COVID-19 vaccine death dialysis disease dose doses Efficacy first dose Follow-up group groups healthy control Hemodialysis homologous or heterologous Immunocompromised patients Immunoglobulin inactivated Inactivated vaccine incidence intensive care kidney Kidney disease kidney transplant kidney transplant recipient Kidney transplantation negative correlation Participants Patient patients peaked performed proportion prospective observational study SARAS-CoV-2 SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 vaccine Seroconversion significantly therapy Vaccination strategy Vaccine vaccine dose Vaccines was recorded
[DOI] 10.1002/jmv.27714 PMC 바로가기 [Article Type] Observational Study